There is a short-term trend in prices of companies, which activity concerns eye treatment. The aggregated price of Alimera Sciences and pSivida Corporation declined by 10.62 percent since last Thursday. There are two short summaries concerning fundamental data of both stocks:
It is easy to notice that the fundamental characteristics of both companies are similar.
There is no new information, which may have an impact on current price. The only info, which was published at the beginning of trend was about $25 Million payment under pSivida's out-license of drug (more info in article below). Probably the prices of those stocks bounced off resistance lines.
Drug Manufacturers - Major, Drug Delivery
Trend Strength: *****, Change: -10.62% Trend start: Thursday, 2014-10-30 13:15